Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
Author:
Publisher
Wiley
Subject
Hepatology
Reference24 articles.
1. A One-Year Trial of Lamivudine for Chronic Hepatitis B
2. Lamivudine and intron a combination treatment in patients with chronic hepatitis B infection
3. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
4. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
Cited by 396 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Overview of the development of HBV small molecule inhibitors;European Journal of Medicinal Chemistry;2023-03
2. A case with relapsed Fanconi syndrome due to administration of tenofovir alafenamide for chronic hepatitis B;Kanzo;2023-01-31
3. FDA approved five-membered ring fused pyrimidine-based derivatives and their biological properties;Fused Pyrimidine-Based Drug Discovery;2023
4. Telbivudine Plus Adefovir Versus Lamivudine Plus Adefovir for Lamivudine-Resistant Chronic Hepatitis B: TeSLA Randomized Trial;Hepatitis Monthly;2022-01-23
5. Retrospective analysis of the clinical characteristics of adefovir dipivoxil–induced Fanconi’s syndrome in the Chinese population;Journal of Clinical Pharmacy and Therapeutics;2020-05-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3